With $65M in funding, UNC spinout Pinnacle Hill backs professor’s blood cancer research
Pinnacle Hill, the drug spinout company formed in partnership with UNC and Deerfield Management, recently said it would support a project led by Lindsey Ingerman James, Ph.D., a UNC Eshelman School of Pharmacy chemical biology and medicinal chemistry division assistant professor.
Read More